In cooperation with the Food and Drug Administration, Honeywell has recalled one lot of Eyesaline Eyewash solution. The eyewash is used for emergency eye rinsing after an injury.
The product has been recalled as a precaution because of the risk of Klebsiella pneumoniae contamination. According to the Centers for Disease Control and Prevention (CDC), the Klebsiella bacteria can cause infections including pneumonia, bloodstream infections, wound or surgical site infections, and meningitis.
To date, not infections have been reported. Honeywell has not found any contamination in its batch testing. But if Klebsiella is present in the eyewash, the bacteria could cause an infection that could threaten eyesight.
Eyesaline Eyewash is sold through industrial products distributors. Approximately 9,700 32-ounce bottles of Eyesaline Eyewash, lot number F16091-61, are included in the recall. No other lot number of the eyewash is subject to recall.
Honeywell said it has notified distributors by phone, e-mail and certified mail, and has instructed them to notify their customers of the recall. All distributors must stop distributing the affected Eyesaline Eyewash and return the bottles to Honeywell for credit or replacement.
Honeywell asked commercial-industrial users to check whether the Eyesaline Eyewash they have on hand is subject to the recall. If it is, the customer should stop using the solution and contact their distributor for replacement or credit.
The recalled product is the 32-ounce bottles of Eyesaline Eyewash, lot number F16091-61. (No other lot number is subject to recall.) The lot number can be found on the outside of the product case and on individual bottles, as shown on the right below. Images of the case and bottles can be seen in the recall announcement on the FDA website.
For questions about the recall, customers can contact their distributor or Honeywell Customer Care at 1-800-430-5490, Monday – Friday, 8:00 a.m. to 6:30 p.m. EST. Any individual who experiences an eye problem that may be related to using this product should contact their physician or a health care provider.
The FDA encourages doctors and patients to report adverse reactions or quality problems to the FDA’s MedWatch Adverse Event Reporting program. Reports can be made online, by regular mail, or by fax.
